Alphabetical. Schedule to be announced shortly.
Postdoctoral Fellow, Johns Hopkins School of Medicine
“The Johns Hopkins Club Drug Study”
Clinical Psychologist and Researcher, Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center
“Exploring MDMA-Assisted Therapy as a Social Adaptability Catalyst for Autistic Adults”
Director of Communications Strategy, Drug Policy Alliance
“Envisioning Success: What Does the End of Psychedelic Criminalization Really Look Like?”
Rick Doblin, Ph.D.
Natalie Lyla Ginsberg
Rick Doblin, Ph.D., MAPS Founder and Executive Director
Natalie Lyla Ginsberg, MAPS Policy and Advocacy Manager
“Rescheduling MDMA: History and Future”
Countess of Wemyss and March, English artist and founder of the Beckley Foundation
“The Beckley Foundation: History and Future”
Professor in the Departments of Psychiatry and Neurosciences, Johns Hopkins University School of Medicine
“The Johns Hopkins Psilocybin Research Project: Overview, Phenomenology, and Therapeutic Applications”
Founder & organizer of the Council on Spiritual Practices
Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS), in Guadalajara, Mexico, co-founder and editor of the Nucleus for Interdisciplinary Studies of Psychoactives (NEIP)
“Ayahuasca Research and Politics”
Lead Clinical Investigator and Medical Monitor, MDMA-Assisted Psychotherapy for PTSD
“MDMA-Assisted Psychotherapy: History and Future”
Associate Professor of Psychiatry and Child & Adolescent Psychiatry at New York University School of Medicine
“The NYU Psilocybin Project: History and Future”
United States Army Brigadier General, Retired, Founding director of the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury
“PTSD, MDMA, and the DOD”
Artist
“Psychedelics and Visionary Art”
Adjunct Professor, School of Population and Public Health, University of British Columbia
Beyond Healing: Psychedelics as Cognitive Tools for Learning
